Jubilant Biosys is an integrated contract research, development and manufacturing organization (CRDMO) and drug discovery company, and a subsidiary of Jubilant Pharmova Limited. With more than 20 years of experience, over 1,200 scientists, and operations in India and France, it supports pharmaceutical and biotechnology companies as they advance drug programs from discovery through development and manufacturing.

Its services span integrated drug discovery, medicinal and synthetic chemistry, assay biology, protein sciences, crystallography, computational chemistry, pharmacology, toxicology, and drug metabolism and pharmacokinetics (DMPK). The company also provides large-molecule discovery capabilities, including antibody-drug conjugate and monoclonal antibody services, as well as recombinant protein production. Its CDMO offerings include process research and development, analytical development, process safety studies, technology transfer, and GLP, non-GMP, and GMP manufacturing for small molecules and biologics.

Jubilant Biosys operates research and development facilities in India and France, alongside API and CDMO manufacturing in Nanjangud, India. Its work combines scientific expertise and advanced technologies with stated commitments to quality, safety, sustainability, and community support.